MorphoSys Aktie
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Werbung
Kursziele im Branchenvergleich
Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
---|---|---|---|---|---|
Agennix AG | 0 | 0 | 0 | - | - |
Amgen Inc. | 0 | 0 | 0 | - | - |
Bayer | 2 | 7 | 0 | 26,88 EUR | -9,00% |
BB Biotech AG | 0 | 0 | 0 | - | - |
Biogen Inc | 0 | 0 | 0 | - | - |
Biotest AG | 0 | 0 | 0 | - | - |
Eli Lilly | 1 | 0 | 0 | 994,00 USD | +20,42% |
EVOTEC SE | 2 | 2 | 0 | 8,42 EUR | +32,72% |
Johnson & Johnson | 0 | 0 | 0 | - | - |
MorphoSys | 0 | 0 | 0 | - | - |
Novartis AG | 3 | 4 | 2 | 98,25 CHF | -5,55% |
Pfizer Inc. | 3 | 4 | 0 | 29,33 USD | +7,79% |
QIAGEN N.V. | 4 | 1 | 0 | 50,00 EUR | +31,77% |
Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
Sanofi S.A. | 8 | 1 | 0 | 110,75 EUR | +33,82% |